Impact of Age on the Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia

Overview of attention for article published in Cardiovascular Drugs and Therapy, February 2019

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (69th percentile)
Good Attention Score compared to outputs of the same age and source (76th percentile)

So far, Altmetric has seen 10 X posts from 9 X users, with an upper bound of 43,708 followers.

RT @SABOURETCardio: Impact of Age on the Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia. - P…

RT @TheFHFoundation: Alirocumab #PCSK9 significantly lowered #cholesterol for individuals with familial hypercholesterolemia on #statins. #…

Impact of Age on the Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia. #KnowFH https://t.co/hQAgzgyJeo https://t.co/aXq9wHfYrg

RT @SABOURETCardio: Impact of Age on the Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia. - P…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 6 additional X posts.